CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.

CCN3/nephroblastoma overexpressed belongs to the CCN family of genes that encode secreted proteins associated with the extracellular matrix (ECM) and exert regulatory effects at the cellular level. Overexpression of CCN3 was shown in metastatic melanoma cells compared with cells of the primary tumor from the same patient. Analysis of short-term cultures from 50 primary and metastatic melanomas revealed a heterogeneous expression pattern of both the 46-kDa full-length cytoplasmic/secreted protein and the 32-kDa nuclear-truncated form. The different protein expression patterns were not associated with gene alterations or polymorphisms. Like the metastatic cells expressing high levels of the 46-kDa CCN3, cells transfected to overexpress CCN3 showed increased adhesion to ECM proteins, whereas inhibition of CCN3 expression by small interfering RNA decreased adhesion to laminin and vitronectin. CCN3 overexpression induced increased expression of laminin and vitronectin integrin receptors alpha 7 beta 1 and alpha v beta 5 by increasing their mRNA production. Moreover, CCN3 secreted by melanoma cells acted as an adhesion matrix protein for melanoma cells themselves. Analysis of CCN3 protein expression with respect to melanoma progression detected the protein in all visceral metastases tested and in most nodal metastases from relapsing patients but in only a few nodal metastases from nonrelapsing patients and cutaneous metastases. Consistently, xenotransplantation in immunodeficient mice showed a higher metastatic potential of melanoma cells overexpressing CCN3. Together, these data indicate a role for CCN3 in melanoma cell interaction with the ECM by regulating integrin expression, resulting in altered cell adhesion and leading melanoma progression to aggressive disease.

[1]  A. Llombart‐Bosch,et al.  Domain-specific CCN3 antibodies as unique tools for structural and functional studies , 2007, Journal of Cell Communication and Signaling.

[2]  A. Ori,et al.  Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulation , 2007, Journal of cellular biochemistry.

[3]  T. Enver,et al.  NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells , 2007, Science.

[4]  N. Hayward,et al.  Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. , 2007, Cancer research.

[5]  Andrew Leask,et al.  All in the CCN family: essential matricellular signaling modulators emerge from the bunker , 2006, Journal of Cell Science.

[6]  M. Herlyn,et al.  CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1 , 2006, The Journal of cell biology.

[7]  Adam Byron,et al.  Integrin ligands at a glance , 2006, Journal of Cell Science.

[8]  A. Whetton,et al.  A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. , 2006, Blood.

[9]  S. Saule,et al.  Nuclear addressing provides a clue for the transforming activity of amino‐truncated CCN3 proteins , 2006, Journal of cellular biochemistry.

[10]  D. Schadendorf,et al.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.

[11]  N. Chegini,et al.  CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells. , 2006, Molecular human reproduction.

[12]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[13]  M. Herlyn,et al.  Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.

[14]  M. Colombo,et al.  In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type , 2005, Oncogene.

[15]  M. Takigawa,et al.  CCN Proteins: A New Family of Cell Growth And Differentiation Regulators , 2005 .

[16]  A. Bosserhoff,et al.  Integrin signaling in malignant melanoma , 2005, Cancer and Metastasis Reviews.

[17]  M. Takigawa,et al.  THE CCN FAMILY OF PROTEINS: AN OVERVIEW , 2005 .

[18]  L. Lau,et al.  Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3) , 2005, Journal of Biological Chemistry.

[19]  M. Laurent,et al.  NOV/CCN3 Induces Adhesion of Muscle Skeletal Cells and Cooperates with FGF2 and IGF-1 to Promote Proliferation and Survival , 2005, Cell communication & adhesion.

[20]  M. Daniotti,et al.  Genetic progression of metastatic melanoma. , 2004, Cancer letters.

[21]  H. Yeger,et al.  Potential cellular conformations of the CCN3(NOV) protein , 2004, Cell Communication and Signaling.

[22]  M. Pierotti,et al.  BRAF alterations are associated with complex mutational profiles in malignant melanoma , 2004, Oncogene.

[23]  B. Perbal CCN proteins: multifunctional signalling regulators , 2004, The Lancet.

[24]  H. Kleinman,et al.  NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR‐α‐dependent mechanism , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  N. Planque,et al.  A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis , 2003, Cancer Cell International.

[26]  L. Lau,et al.  CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family* , 2003, Journal of Biological Chemistry.

[27]  M. Hyvönen,et al.  Adhesion of Endothelial Cells to NOV Is Mediated by the Integrins αvβ3 and α5β1 , 2003, Journal of Vascular Research.

[28]  F. Lallemand,et al.  The Expression of novH in Adrenocortical Cells Is Down-regulated by TGFβ1 through c-Jun in a Smad-independent Manner* , 2002, The Journal of Biological Chemistry.

[29]  Arnoud Sonnenberg,et al.  Function and interactions of integrins , 2001, Cell and Tissue Research.

[30]  B. Perbal NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues , 2001, Molecular pathology : MP.

[31]  Qin Chen,et al.  Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[32]  L. Lau,et al.  The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.

[33]  P. Schofield,et al.  novH: differential expression in developing kidney and Wilm's tumors. , 1998, The American journal of pathology.

[34]  K. von der Mark,et al.  Specific Induction of Cell Motility on Laminin by 7 Integrin (*) , 1996, The Journal of Biological Chemistry.

[35]  V. Joliot,et al.  Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.

[36]  R. Timpl,et al.  Laminin-binding integrin alpha 7 beta 1: functional characterization and expression in normal and malignant melanocytes. , 1991, Cell regulation.

[37]  R. Kramer,et al.  Human melanoma cells express a novel integrin receptor for laminin. , 1989, The Journal of biological chemistry.

[38]  B. Perbal The CCN3 protein and cancer. , 2006, Advances in experimental medicine and biology.

[39]  M. Ginsberg,et al.  Integrin regulation. , 2005, Current opinion in cell biology.

[40]  Judith P. Johnson Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma , 2004, Cancer and Metastasis Reviews.

[41]  D. Brewster,et al.  Trends in cancer incidence and mortality in Scotland: description and possible explanations. , 1998, British Journal of Cancer.

[42]  N. J. McNally,et al.  United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.

[43]  R. Timpl,et al.  Laminin-binding integrin α7β1 : functional characterization and expression in normal and malignant melanocytes , 1991 .